| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.balpharma.com | |
| Market Cap | 159.47 Cr. | |
| Enterprise Value(EV) | 292.16 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 2.23 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 45.32 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.22 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 40.63 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 2.48 | Calculated using Price: 100.88 |
| Dividend Yield | 0.99 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.58 Cr. | 15,808,372 Shares |
| FaceValue | 10 | |
| About Bal Pharma Ltd. | ||
| Bal Pharma, incorporated in 1987 is engaged in the business interest in area of manufacturing API, finished formulations, ayurvedic and research and development. It is one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives. | ||
| 1 Day |
|
-0.64% |
| 1 Week |
|
+2.29% |
| 1 Month |
|
+1.72% |
| 3 Month |
|
-11.09% |
| 6 Month |
|
+16.98% |
| 1 Year |
|
+17.73% |
| 2 Year |
|
-12.67% |
| 5 Year |
|
+41.79% |
| 10 Year |
|
+192.02% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 7 | 0.49 | -0.69 | 0.59 | 3.27 | -21.65 | 8.97 | 10.34 | 4.31 | |
| Return on Capital Employed (%) | 10.88 | 7.35 | 7.59 | 7.45 | 6.88 | -0.44 | 9.72 | 12.33 | 9.56 | |
| Return on Assets (%) | 2.23 | 0.14 | -0.18 | 0.15 | 0.83 | -5.16 | 1.97 | 2.28 | 0.92 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 55 | 55 | 62 | 65 | 67 | 52 | 54 | 59 | 64 | 63 | |
| Non Curr. Liab. | 16 | 45 | 30 | 46 | 38 | 34 | 34 | 36 | 38 | 36 | |
| Curr. Liab. | 92 | 111 | 143 | 154 | 163 | 159 | 153 | 166 | 209 | 229 | |
| Minority Int. | 0 | 0 | -2 | -5 | -6 | -7 | 0 | 0 | 0 | 0 | |
| Equity & Liab. | 164 | 211 | 233 | 260 | 261 | 238 | 240 | 261 | 311 | 328 | |
| Non Curr. Assets | 59 | 68 | 69 | 75 | 78 | 81 | 76 | 76 | 83 | 83 | |
| Curr. Assets | 105 | 143 | 165 | 185 | 183 | 157 | 164 | 185 | 228 | 244 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 164 | 211 | 233 | 260 | 261 | 238 | 240 | 261 | 311 | 328 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 187 | 198 | 229 | 209 | 225 | 171 | 251 | 281 | 304 | 327 | |
| Other Income | 1 | 1 | 3 | 2 | 1 | 2 | 1 | 5 | 1 | 1 | |
| Total Income | 188 | 200 | 232 | 211 | 226 | 173 | 252 | 286 | 305 | 328 | |
| Total Expenditure | -170 | -183 | -214 | -192 | -207 | -166 | -226 | -257 | -279 | -297 | |
| PBIDT | 18 | 16 | 18 | 19 | 19 | 7 | 26 | 29 | 26 | 31 | |
| Interest | -7 | -6 | -8 | -9 | -13 | -13 | -12 | -11 | -12 | -15 | |
| Depreciation | -7 | -7 | -6 | -7 | -6 | -8 | -10 | -9 | -9 | -10 | |
| Taxation | -1 | -2 | -3 | -3 | 2 | 1 | 1 | -3 | -2 | -2 | |
| Exceptional Items | |||||||||||
| PAT | 4 | 0 | 0 | 0 | 2 | -13 | 5 | 6 | 3 | 4 | |
| Minority Interest | 0 | 1 | 2 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | |
| Share Associate | |||||||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | 4 | 1 | 2 | 3 | 4 | -12 | 5 | 6 | 3 | 4 | |
| Adjusted EPS | 3 | 1 | 1 | 2 | 3 | -9 | 3 | 4 | 2 | 2 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 13 | 15 | -19 | 6 | 1 | 8 | 23 | 22 | 27 | -2 | |
| Cash Fr. Inv. | -7 | -5 | -14 | -8 | -4 | -8 | -5 | -6 | -9 | -22 | |
| Cash Fr. Finan. | -8 | -7 | 32 | -6 | 4 | 0 | -20 | -17 | -17 | 24 | |
| Net Change | -2 | 2 | -1 | -8 | 1 | 0 | -1 | 0 | 0 | 0 | |
| Cash & Cash Eqvt | 3 | 5 | 5 | -25 | 3 | 2 | 1 | 1 | 1 | 1 |
|
Tue, 23 Apr 2024
Disclosure under SEBI Takeover Regulations Bal Pharma Limitedￂﾠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaￂﾠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 |
|
Thu, 18 Apr 2024
Statement of deviation(s) or variation(s) under Reg. 32 Bal Pharma Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 |
|
Wed, 17 Apr 2024
Loss/Duplicate-Share Certificate-XBRL BAL PHARMA LIMITED has informed the Exchange about Loss of share certificates |
| Wed, 24 Apr 2024 |
Making Higher Highs for 2 Days
|
High Decrease in 3 Months
|
RSI Trending Down
|
William %R Trending Down
|
ROC Trending Down
|
